Frequently Asked Questions

A clinical trial is a carefully designed research study that tests whether a new treatment, medication, device, or care strategy is safe and effective in people. Trials follow a detailed protocol approved by an Institutional Review Board (IRB) and are conducted in phases, each answering specific questions about safety and benefit. At Dow Health Research, every study is overseen by board-certified physicians and trained coordinators who guide you through the process and monitor your health from your first visit through completion.

Each study has its own eligibility criteria — factors such as age, medical history, current medications, and specific health conditions. The fastest way to find out is to submit our secure Join a Study form. A coordinator reviews your information confidentially and contacts you to discuss studies you may match. There is no cost and no obligation to enroll, and qualifying for pre-screening never commits you to participating.

Participant safety is our highest priority. Before any trial begins, the protocol is reviewed and approved by an independent Institutional Review Board (IRB) and conducted under Good Clinical Practice (GCP) and FDA regulations. Throughout the study, our medical team monitors participants closely for any side effects, and an informed consent process explains all known risks and benefits before you decide. You are also free to ask questions at any time and to stop participating whenever you choose.

Many studies provide compensation for the time and travel involved in participating, and some also cover study-related procedures at no cost to you. The exact amount varies by study based on the number of visits, their length, and the procedures required, and it is always explained in writing during the informed consent process before you enroll. Compensation is never used to pressure anyone into joining — it is intended to fairly recognize your time and contribution.

A screening visit confirms whether a specific study is a good fit for you. It typically includes a review of your medical history, a discussion of the study and its requirements, and may involve basic health checks such as vital signs or lab work. The coordinator walks you through the informed consent document, answers your questions, and gives you time to decide. Nothing happens without your written consent, and you may decline at any point.

Yes. Participation in a clinical trial is always completely voluntary. You may withdraw at any time, for any reason, without penalty and without affecting your regular medical care. If you choose to leave a study, our team will explain any steps needed to do so safely.

No. Taking part in a clinical trial does not replace your relationship with your regular physician. With your permission, our team can coordinate with your existing healthcare providers so your overall care stays consistent. You remain free to continue seeing your own doctor throughout the study.

Dow Health Research conducts studies across a range of therapeutic areas, including nephrology, internal medicine, dermatology, pain management, metabolic disorders such as diabetes, and CNS and behavioral health. Available studies change over time, so the best way to see what is currently enrolling is to contact us or submit the Join a Study form.

A Site Management Organization (SMO) manages the operational side of clinical trials at the research-site level — handling site identification and feasibility, study start-up, patient recruitment and retention, regulatory compliance, and day-to-day clinical operations. By centralizing these functions, an SMO like Dow Health Research helps sponsors and CROs activate sites faster, enroll patients more reliably, and maintain consistent data quality across a network of locations.

Our team supports a broad range of therapeutic areas, including nephrology, internal medicine, dermatology, pain management, metabolic disorders (including diabetes), and CNS and behavioral health. We continually expand our capabilities based on investigator expertise and the needs of our sponsor partners.

Dow Health Research supports Phase I through Phase IV clinical trials, with full operational and recruitment capabilities at each stage — from early safety studies through large post-marketing research.

Timelines depend on the protocol and regulatory requirements, but our start-up process is built for speed and predictability, with clear milestone tracking from contract through site initiation. We work to compress activation timelines without compromising compliance or quality.

The simplest first step is to complete the inquiry form on our Sponsors & CROs page. A business development representative will respond within one business day to discuss your program, our site network, therapeutic fit, and feasibility for your study.